|
Aug 11
|
Merck KGaA Second Quarter 2025 Earnings: Misses Expectations
|
|
Aug 8
|
EpiPen patent expiry opens new era for innovation
|
|
Aug 7
|
Catalyzing Change in Chemistry Education: Key Takeaways From the 2025 ACS Green Chemistry & Engineering Conference
|
|
Aug 7
|
C4 Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
|
|
Aug 7
|
Germany’s Merck Raises Earnings Growth Guidance, But Turns Cautious on Sales
|
|
Aug 6
|
[Latest] Global Arabinogalactan Market Size/Share Worth USD 312 Million by 2034 at a 4.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
|
|
Aug 6
|
RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
|
|
Aug 1
|
Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices
|
|
Aug 1
|
Sodium Perborate Company Evaluation Report 2025 | Thermo Fisher, Merck KGaA, and Evonik Treibacher Lead with Strategic Expansions, Strong Distribution, and Eco-Friendly Innovation
|
|
Aug 1
|
European drugmakers fall after Trump raises stakes over US drug price cuts
|
|
May 1
|
MKKGY vs. ZTS: Which Stock Is the Better Value Option?
|
|
May 1
|
Are Investors Undervaluing Merck KGaA (MKKGY) Right Now?
|
|
Jun 7
|
Germany’s Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions – Interview
|
|
Jun 6
|
Merck opens $195.7m expanded distribution centre in Germany
|
|
May 15
|
Health Care Roundup: Market Talk
|
|
May 13
|
Lula’s progress plan for Brazil: A year on
|
|
Dec 8
|
Merck Navigates Chip Geopolitics With ‘China For China’ Strategy
|
|
Dec 6
|
Merck KGaA: MS drug failure is a sour note for growth hopes
|
|
Dec 6
|
German Merck’s MS drug falls short in pair of Phase 3 tests
|
|
Dec 6
|
Merck KGaA Plunges as Multiple Sclerosis Drug Fails in Trial
|